Facebook (FB) Market Valuation Rose While Sand Hill Global Advisors Has Cut Its Holding by $7.89 Million; Capital International Sarl Upped Its Position in Gilead Sciences (GILD) by $519,210

February 15, 2018 - By Marguerite Chambers

Sand Hill Global Advisors Llc decreased its stake in Facebook Inc (FB) by 92.86% based on its latest 2017Q3 regulatory filing with the SEC. Sand Hill Global Advisors Llc sold 46,435 shares as the company’s stock rose 10.88% with the market. The institutional investor held 3,570 shares of the technology company at the end of 2017Q3, valued at $610,000, down from 50,005 at the end of the previous reported quarter. Sand Hill Global Advisors Llc who had been investing in Facebook Inc for a number of months, seems to be less bullish one the $515.73 billion market cap company. The stock decreased 1.11% or $1.99 during the last trading session, reaching $177.53. About 8.91M shares traded. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since February 15, 2017 and is uptrending. It has outperformed by 10.05% the S&P500.

Capital International Sarl increased its stake in Gilead Sciences Inc (GILD) by 18.09% based on its latest 2017Q3 regulatory filing with the SEC. Capital International Sarl bought 6,410 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 41,850 shares of the health care company at the end of 2017Q3, valued at $3.39 million, up from 35,440 at the end of the previous reported quarter. Capital International Sarl who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $106.63B market cap company. The stock decreased 0.23% or $0.19 during the last trading session, reaching $81.63. About 2.54 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 15, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Capital International Sarl, which manages about $1.20B US Long portfolio, decreased its stake in Mercadolibre Inc (NASDAQ:MELI) by 4,100 shares to 126,650 shares, valued at $32.79M in 2017Q3, according to the filing. It also reduced its holding in Enel Americas Sa Adr (NYSE:ENI) by 88,000 shares in the quarter, leaving it with 1.65 million shares, and cut its stake in America Movil Sab De Cv L Adr (NYSE:AMX).

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It improved, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Carnegie Asset Management Ltd Co holds 0.09% or 9,153 shares in its portfolio. Strategic Glob Llc reported 1.28% stake. Argent Trust stated it has 0.35% in Gilead Sciences, Inc. (NASDAQ:GILD). Oregon Pub Employees Retirement Fund stated it has 0.96% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). First Allied Advisory Services Incorporated reported 0.38% in Gilead Sciences, Inc. (NASDAQ:GILD). Perella Weinberg Prtnrs Capital Mngmt LP owns 0.05% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 6,928 shares. Mutual Of America Cap Management Limited Liability Company stated it has 0.28% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Linscomb & Williams holds 6,046 shares or 0.04% of its portfolio. Bokf Na, a Oklahoma-based fund reported 98,026 shares. Aureus Asset Mgmt Limited Company accumulated 4,832 shares. Moreover, Institute For Wealth Mgmt Lc has 0.34% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 12,888 shares. Sg Americas Secs Llc has invested 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Rafferty Asset Mngmt Ltd Llc holds 0.03% or 18,984 shares in its portfolio. State Of Alaska Department Of Revenue invested in 7,070 shares or 0.03% of the stock. Keybank Association Oh reported 0.26% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD).

Since August 30, 2017, it had 0 insider purchases, and 13 insider sales for $51.09 million activity. Shares for $1.11M were sold by Alton Gregg H. MARTIN JOHN C had sold 50,000 shares worth $4.18 million on Thursday, February 1. Washington Robin L also sold $4.40M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. UBS maintained it with “Buy” rating and $118 target in Friday, April 29 report. The firm has “Overweight” rating by Piper Jaffray given on Wednesday, February 3. On Monday, October 16 the stock rating was maintained by Robert W. Baird with “Buy”. As per Thursday, July 27, the company rating was maintained by Maxim Group. The firm earned “Buy” rating on Wednesday, November 8 by Mizuho. The rating was maintained by Leerink Swann with “Market Perform” on Thursday, October 5. As per Friday, January 15, the company rating was upgraded by Bank of America. The company was initiated on Wednesday, October 4 by Oppenheimer. The firm has “Market Perform” rating by Leerink Swann given on Thursday, October 19. Mizuho maintained the shares of GILD in report on Sunday, October 29 with “Buy” rating.

Since August 14, 2017, it had 0 insider buys, and 33 selling transactions for $395.73 million activity. Schroepfer Michael Todd sold $7.14 million worth of stock or 38,017 shares. Cox Christopher K sold $2.67 million worth of Facebook, Inc. (NASDAQ:FB) on Monday, August 21. 15,470 shares valued at $2.59M were sold by Wehner David M. on Monday, August 21. $21.25 million worth of stock was sold by Zuckerberg Mark on Friday, December 8. Another trade for 5,587 shares valued at $1.05M was sold by FISCHER DAVID B.. Another trade for 2.95 million shares valued at $502.59 million was sold by Koum Jan.

Among 54 analysts covering Facebook (NASDAQ:FB), 50 have Buy rating, 2 Sell and 2 Hold. Therefore 93% are positive. Facebook had 236 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Facebook, Inc. (NASDAQ:FB) earned “Buy” rating by Deutsche Bank on Monday, January 29. The rating was maintained by Canaccord Genuity on Wednesday, January 31 with “Buy”. Goldman Sachs maintained the shares of FB in report on Thursday, July 30 with “Buy” rating. As per Friday, July 21, the company rating was maintained by Deutsche Bank. The firm earned “Buy” rating on Thursday, October 8 by Argus Research. The rating was maintained by SunTrust on Thursday, April 28 with “Buy”. As per Thursday, November 5, the company rating was maintained by Canaccord Genuity. The stock of Facebook, Inc. (NASDAQ:FB) has “Outperform” rating given on Monday, October 17 by Credit Suisse. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Thursday, November 3 by Jefferies. Cowen & Co maintained it with “Buy” rating and $19500 target in Thursday, July 27 report.

Sand Hill Global Advisors Llc, which manages about $1.31 billion and $937.60M US Long portfolio, upped its stake in Ishares Tr (IWM) by 321,423 shares to 323,284 shares, valued at $47.90 million in 2017Q3, according to the filing. It also increased its holding in Vanguard Intl Equity Index F (VGK) by 495,234 shares in the quarter, for a total of 1.09 million shares, and has risen its stake in Wells Fargo Co New (NYSE:WFC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>